Skip to content

Patient Perception Questionnaire Validation

Validation of the Patient Perception Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02067000
Enrollment
217
Registered
2014-02-20
Start date
2011-04-30
Completion date
2012-04-30
Last updated
2020-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Validation of the patient perception questionnaire relating to CPAP use

Detailed description

This research is designed to validate a questionnaire which aims to predict patient adherence to CPAP, therefore enabling the healthcare provider to better target initiatives to improve adherence.

Interventions

BEHAVIORALObstructive Sleep Apnea

Questionnaire about CPAP perceptions

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mild-severe OSA patients * Over 18 * Naive to CPAP * Fluent english

Exclusion criteria

* Comorbidities * Other sleep disorders * Inability to tolerate CPAP * Shift worker

Design outcomes

Primary

MeasureTime frameDescription
To Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Baseline and 90 daysThe PPQ is a custom questionnaire including 10 questions evaluating perceptions of OSA and CPAP treatment. Each question is derived from models of psychology such as self-regulatory ability and social support. Q1 ranges from 0-10, with 10 indicating OSA negatively impacts life. Q2 ranges from 0-10, with 10 indicating belief that OSA will last forever. Q3 ranges from 0-10, with 10 indicating that CPAP is extremely necessary to control OSA. Q4 ranges from 1-10, with 10 indicating no intention of using CPAP at all. Q5 ranges from 1-10, with 10 indicating presence of a highly supportive spouse. Q6 ranges from 1-10, with 10 indicating benefit of CPAP is well understood. Q7 ranges from 0-10, with 10 indicating extreme concern about using CPAP. Q8 ranges from 1-10, with 10 indicating high confidence with using CPAP. Q9 ranges from 1-10, with 10 indicating high perception that CPAP will help treat OSA. Q10 ranges from 1-10, with 10 indicating spouses negative attitude toward CPAP use.

Secondary

MeasureTime frameDescription
Adherence to CPAP Treatment14 Days, 60 Days, 90 DaysAn assessment of participants adherence to CPAP treatment after 90 days. Data was extracted from CPAP device compliance reports.Adherence was defined as use for 4 hours or more per night for 70% of nights in each report period at 14, 60 and 90 days.
Reliability of Patient Perception Questionnaire14 days, 60 days, 90 daysTo determine the stability/consistency (reliability) of the PPQ at three time points during the first 90 days of CPAP treatment usage. At each of these time points, the exact same PPQ as described in the Primary Outcome Measure was re-administered to determine whether the scores remained consistent over time. The answer responses described in the Primary Outcome measure also remain the same. Total PPQ was calculated as an average of the 10 questions. Total score ranges from 0-10 with higher scores indicating a worse outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Obstructive Sleep Apnea
Obstructive Sleep Apnea: Questionnaire about CPAP perceptions
217
Total217

Baseline characteristics

CharacteristicObstructive Sleep Apnea
Age, Continuous54.1 Years
Race/Ethnicity, Customized
Caucasian
170 Participants
Race/Ethnicity, Customized
Other
47 Participants
Region of Enrollment
United States
217 participants
Sex: Female, Male
Female
104 Participants
Sex: Female, Male
Male
113 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 217
other
Total, other adverse events
0 / 217
serious
Total, serious adverse events
0 / 217

Outcome results

Primary

To Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.

The PPQ is a custom questionnaire including 10 questions evaluating perceptions of OSA and CPAP treatment. Each question is derived from models of psychology such as self-regulatory ability and social support. Q1 ranges from 0-10, with 10 indicating OSA negatively impacts life. Q2 ranges from 0-10, with 10 indicating belief that OSA will last forever. Q3 ranges from 0-10, with 10 indicating that CPAP is extremely necessary to control OSA. Q4 ranges from 1-10, with 10 indicating no intention of using CPAP at all. Q5 ranges from 1-10, with 10 indicating presence of a highly supportive spouse. Q6 ranges from 1-10, with 10 indicating benefit of CPAP is well understood. Q7 ranges from 0-10, with 10 indicating extreme concern about using CPAP. Q8 ranges from 1-10, with 10 indicating high confidence with using CPAP. Q9 ranges from 1-10, with 10 indicating high perception that CPAP will help treat OSA. Q10 ranges from 1-10, with 10 indicating spouses negative attitude toward CPAP use.

Time frame: Baseline and 90 days

ArmMeasureGroupValue (NUMBER)
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q1.04 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q2.14 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q3.10 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q5.25 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q6.01 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q7.29 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q8.16 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q9.12 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q10.19 r value
Obstructive Sleep ApneaTo Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.Q4.13 r value
Secondary

Adherence to CPAP Treatment

An assessment of participants adherence to CPAP treatment after 90 days. Data was extracted from CPAP device compliance reports.Adherence was defined as use for 4 hours or more per night for 70% of nights in each report period at 14, 60 and 90 days.

Time frame: 14 Days, 60 Days, 90 Days

ArmMeasureGroupValue (MEAN)Dispersion
Obstructive Sleep ApneaAdherence to CPAP Treatment60 Days322 MinutesStandard Deviation 118
Obstructive Sleep ApneaAdherence to CPAP Treatment90 Days317 MinutesStandard Deviation 119
Obstructive Sleep ApneaAdherence to CPAP Treatment14 Days335 MinutesStandard Deviation 118
Secondary

Reliability of Patient Perception Questionnaire

To determine the stability/consistency (reliability) of the PPQ at three time points during the first 90 days of CPAP treatment usage. At each of these time points, the exact same PPQ as described in the Primary Outcome Measure was re-administered to determine whether the scores remained consistent over time. The answer responses described in the Primary Outcome measure also remain the same. Total PPQ was calculated as an average of the 10 questions. Total score ranges from 0-10 with higher scores indicating a worse outcome.

Time frame: 14 days, 60 days, 90 days

Population: Due to missing or incomplete data and drop outs, only participants who had completed all 10 questions of the PPQ were included in the analysis for each timepoint.

ArmMeasureGroupValue (MEAN)Dispersion
Obstructive Sleep ApneaReliability of Patient Perception Questionnaire60 days6.35 units on a scaleStandard Deviation 0.92
Obstructive Sleep ApneaReliability of Patient Perception Questionnaire90 days6.06 units on a scaleStandard Deviation 1.14
Obstructive Sleep ApneaReliability of Patient Perception Questionnaire14 days6.43 units on a scaleStandard Deviation 0.99

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026